MedPath

fMRI Analysis of Aging and Awareness in Conditioning

Not Applicable
Active, not recruiting
Conditions
Transcranial Direct Current Stimulation
Interventions
Device: transcranial direct current stimulation
Device: sham transcranial direct current stimulation
Registration Number
NCT03655769
Lead Sponsor
Johns Hopkins University
Brief Summary

Cathodal Transcranial direct current stimulation (tDCS) was administered to the right parietal region in order to determine if this stimulation could disrupt awareness of the conditioned stimulus (CS) - unconditioned stimulus (US) relationship in a classical conditioning experiment.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Educational attainment of at least eight years and English as the native language
  • Mini-Mental State Examination (MMSE) score of 26
  • Normal episodic memory (i.e., CERAD word List Recall > 5)
  • Informed consent; 5) age of 20-30
Exclusion Criteria
  • Disturbed consciousness
  • Other neurological or systemic disorder which can cause dementia or cognitive dysfunction
  • Prior history of a major psychiatric disorder
  • History of definite stroke
  • Focal lesion on MRI exam
  • Use of anxiolytic, antidepressant, neuroleptic, or sedative medication
  • Predominately left-handed
  • Has MRI contraindication such as pacemaker, implanted pumps, shrapnel, etc. (full MRI screening form will be filled out).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
cathodal tDCStranscranial direct current stimulationcathodal tDCS, 2 milliamps (mA), delivered to right parietal region
sham tDCSsham transcranial direct current stimulationtDCS delivered for only 30 sec to replicate tingling sensation and blind subject
Primary Outcome Measures
NameTimeMethod
CS-US Awarenessrecorded immediately after the 20 minutes of tDCS stimulation

To assess CS-US awareness, we used a questionnaire The questionnaire consists of 7 true/false questions about the sequence and co-occurrence of the conditioned stimulus (CS, a 1000 Hz tone) and unconditioned stimulus (US, a 100 ms puff of air to the eye). The score can thus range from 0 to 7. Higher score values indicate better awareness of the sequence and co-occurrence of the CS and US

Secondary Outcome Measures
NameTimeMethod
Line bisection test of left-hemifield neglectrecorded immediately after primary awareness questionnaire

The subject is given a sheet of paper with a number of horizontal lines on it. The subject is instructed to cut each line in half by drawing a small pencil mark through each line. The test is scored by measuring the percent deviation, which is calculated by the following formula:

Percent deviation=100 x (measured left half - true half)/true half This yields positive numbers for marks placed to the right of center, and negative numbers for marks placed to the left of center. Patients with right hemisphere damage and contralateral neglect show higher positive line bisection scores compared to healthy controls or patients without right hemisphere damage and vice versa.

Eyeblink conditioned respondingrecorded during the tDCS administration

Eyeblink conditioning is recorded while the subject watches a silent movie. For conditioning, the conditioned stimulus (CS) is a 1350 ms 1000 Hz tone. This tone co-terminates with a 100 ms left corneal airpuff (5 psi). 30 CS-US presentations are delivered at an average rate of one every 18 sec. Conditioned responses (CRs) are defined as follows: the difference between the maximum and minimum responses in a 500 ms pre-US time window must exceed four times the standard deviation of the mean of the baseline period (250 ms pre-CS presentation). The 500 ms pre-US time window was selected to minimize the inclusion of voluntary and alpha responses as CRs. Performance is expressed as % CRs, that is, the percent of trials in which a CR occurred. Greater numbers indicate greater amounts of learning.

© Copyright 2025. All Rights Reserved by MedPath